aiqbench analysis
This finalist submission marks a significant milestone in hybrid computing, demonstrating how coordinated quantum and classical resources can solve previously intractable protein simulation problems. The integration of IBM's Heron processors with RIKEN's supercomputers highlights a practical pathway for scaling molecular research beyond current computational limits. Such advancements are critical for accelerating drug discovery by enabling accurate modeling of complex biological systems that were formerly impossible to simulate.
Cleveland Clinic, RIKEN, IBM named Gordon Bell finalists

Cleveland Clinic, RIKEN & IBM are finalists for the 2026 ACM Gordon Bell Prize, recognizing their 12,635-atom protein simulation—a leap for quantum-enabled computing.
Cleveland Clinic, RIKEN, and IBM are finalists for the 2026 ACM Gordon Bell Prize for a simulation of a 12,635-atom protein, the largest known quantum-enabled simulation of…
Excerpt shown under the publisher's RSS terms · 27 words · full text and figures are on the publisher's site
Related coverage
Cleveland Clinic, RIKEN and IBM Team Advance to Finals for 2026 ACM Gordon Bell Prize
IBM · Sep 9, 2026

RIKEN protein model reaches 12,635 atoms using quantum-classical computing
Quantum Zeitgeist · Sep 13, 2026
Stonebridge Capital Management Inc. Takes Position in International Business Machines Corporation $IBM
themarketsdaily.com · Sep 10, 2026
Public Employees Retirement System of Ohio Acquires New Position in International Business Machines Corporation $IBM
themarketsdaily.com · Sep 10, 2026